FMNL1 and nonpapillary renal cell carcinoma: A series of in vitro experiments revealed that depletion of FMNL1 in 786-O and Caki-1 impaired the proliferation, migration and invasion capacities, respectively, which demonstrated that inhibiting FMNL1 expression contributed to suppress the progression of ccRCC significantly and might be a new effective therapeutic strategy.